Medical Brands Announces the First use of Medical Claims in the OTC for Treating and Preventing Urinary Tract Infections

Cranberry-Active™ Bladder Capsules achieve the first European Union Class IIa Medical Device Status.

AMSTERDAM, Netherlands--()--Medical Brands has obtained a Class IIa medical device status through the appropriate Competent Authorities for Cranberry-Active™, a patented cranberry-based oral capsule clinically shown to support urinary tract health. As a registered Class IIa medical device, Cranberry-Active™ is the only cranberry-based product in the European Economic Area and recognized countries that can be freely marketed with a medical claim for treating and preventing urinary tract infections.

Urinary tract infections (UTIs) are a serious health problem affecting millions of people each year. Today, antibiotics are the traditional treatment for UTIs but there is a growing global push towards other solutions as resistance to antibiotics continues to rise.

“The Cranberry-Active™ marketing authorization is the culmination of years of planning, development and clinical investigation,” said Maikel Hendriks, president of Medical Brands. “The market opportunity is perfectly timed given EFSA’s recent cranberry-based food supplement claim rejections which make any cranberry-based label claims for urinary tract health illegal by the end of 2012. As a result of these market dynamics, partners who launch Cranberry-Active™ will be well-positioned to quickly take a leadership position within UTI treatments in Europe and beyond.”

“We are pleased that Medical Brands chose to work with Decas Botanical Synergies (DBS) on this patented cranberry-based urinary tract health solution,” said Dan Souza, sr. director of sales and marketing for DBS. “Clearly our strong intellectual property, technical knowledge and most importantly our commitment to clinical substantiation was vital to the successful medical device registration approval. You can be rest assured that DBS will continue to be on the leading edge of cranberry ingredient innovations.”

To learn more, Medical Brands and DBS will be presenting Cranberry-Active™ at Vitafoods Europe 2012 in Geneva, Switzerland at the Seminar Theater on Tuesday, May 22nd at 2:00 PM. Contact Medical Brands or DBS to schedule a meeting at the Vitafoods Europe event.

Medical Brands is searching for partners to market Cranberry-Active™ bladder capsules in Europe and the rest of the world.

Note to editors

About Medical Brands

Headquartered in Amsterdam, Netherlands, Medical Brands provides consumers with solutions in the OTC to everyday medical problems. Medical Brands develops patents, registers and provides products to treat and prevent simple every day diseases without pharmacological effects. Medical Brands market and sell products that are registered Medical Devices.

About Decas Botanical Synergies

Headquartered in Carver, Massachusetts, Decas Botanical Synergies, a subsidiary of Decas Cranberry Products, Inc., is a developer, manufacturer and marketer of patented, value-added fruit-derived ingredients for the dietary supplement, functional foods, animal feed and nutrition, personal care and cosmetics and oral health industries.

Contacts

Medical Brands
Maikel Hendriks, +31.20.3455330
President
m.hendriks@medicalbrands.com
www.medicalbrands.com
or
Decas Botanical Synergies, LLC
Dan Souza, +1-774-435-0109
Sr. Director of Sales and Marketing
dsouza@decasbotanical.com
www.decasbotanical.com

Release Summary

Cranberry-Active™ treats and prevents Urinary Tract Infections

Contacts

Medical Brands
Maikel Hendriks, +31.20.3455330
President
m.hendriks@medicalbrands.com
www.medicalbrands.com
or
Decas Botanical Synergies, LLC
Dan Souza, +1-774-435-0109
Sr. Director of Sales and Marketing
dsouza@decasbotanical.com
www.decasbotanical.com